報價延遲最少15分鐘:2026/05/13 23:21 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.08 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.35/--
|
|
企業價值
498.46M
|
| 資產負債 |
|
每股賬面淨值
-0.16
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
502.73M
|
|
每股收益
2.93
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment. |
